| Dr Tonya C Washburn, MD | |
|
6800 Nw 39th Expy, Bethany, OK 73008-2513 | |
| (405) 789-6711 | |
| (405) 438-3834 |
| Full Name | Dr Tonya C Washburn |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 6800 Nw 39th Expy, Bethany, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235101643 | NPI | - | NPPES |
| 100097040A | Medicaid | OK | |
| 250013358 | Other | OK | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 18124 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tonya C Washburn, MD 6800 Nw 39th Expy, Bethany, OK 73008-2513 Ph: (405) 789-6711 | Dr Tonya C Washburn, MD 6800 Nw 39th Expy, Bethany, OK 73008-2513 Ph: (405) 789-6711 |
News Archive
The seventh annual Ready or Not? Protecting the Public's Health from Diseases, Disasters, and Bioterrorism report, released today by the Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF), found that the H1N1 flu outbreak has exposed serious underlying gaps in the nation's ability to respond to public health emergencies and that the economic crisis is straining an already fragile public health system.
Provepharm, a French company specialized in the development of pharmaceutical applications, and Dr Franz Kohler Chemie, a German leader in the manufacture and supply of organ preservation solutions and antidote pharmaceuticals, today announce that they have entered into a partnership to launch Provepharm's drug product Methylthioninium chloride Proveblue 5mg/ml solution for injection (the Product) in Germany, for the acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia.
The generation of high-resolution pictures of hundreds of medically important proteins known as G-protein coupled receptors (GPCRs) will be the goal of an ambitious new international partnership. Called the GPCR Consortium, this non-profit initiative brings together major pharmaceutical companies and leading research institutes from three continents to advance GPCR research for drug development.
Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has commenced a randomized, double-blind, placebo-controlled Pilot Study of up to 165 persons who have type 2 diabetes, the most common form of diabetes.
› Verified 6 days ago
Justin Wayne Ramsey, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-9866 Fax: 405-438-3834 | |
Suneet Sahgal, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-9866 Fax: 405-438-3834 | |
Rachel Nicole Blankenship, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 6800 Nw 39th Expy, Bethany, OK 73008 Phone: 405-440-9866 Fax: 405-438-3834 |